...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
【24h】

Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.

机译:散发性浸润性乳腺癌中16q22.1和16q24.3染色体基因座的变化:与肿瘤的增殖活性,倍性和激素状态相关。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Breast cancer is characterized by complex genetic alterations found in multiple chromosomal regions, most commonly losses of 17p, 16q, 8p and others. A number of tumor suppressor genes mapped on these loci have been investigated in mammary tumors, whereas other gene products are of unclear function and await identification. MATERIALS AND METHODS: We analyzed the loss of heterozygosity (LOH) of two chromosomal loci: a. 16q24.3 using the genetic markers D16S303, D16S3026 and D16S3407 and b. 16q22.1, the locus of E-cadherin gene, using the microsatelite markers D16S503, D16S752 and D16S512, in a series of 63 sporadic invasive breast carcinomas consisting of 56 ductal, 4 lobular and 3 tumors of mixed type. Our findings were correlated with proliferative activity, ploidy and hormonal status of the tumors. RESULTS: Fourteen (22.2%) tumors demonstrated LOH of 16q24.3. Allelic imbalance of the 16q22.1 locus was found in 19 of 61 informative cases (31%) and commonly coexisted with LOH of 16q24.3. A significant association was observed between LOH of D16S752 and the absence of progesterone receptors in tumor cells (p = 0.005). CONCLUSIONS: LOH of 16q24.3 and 16q22.1 are frequent genetic alterations in breast cancer and they do not seem to correlate with tumor cell proliferation or ploidy. The statistical association between LOH of 16q24.3 and progesterone receptors need to be further investigated in larger series.
机译:背景:乳腺癌的特征是在多个染色体区域发现复杂的遗传改变,最常见的是17p,16q,8p等基因的丢失。已经在乳腺肿瘤中研究了定位在这些基因座上的许多抑癌基因,而其他基因产物的功能尚不清楚,尚待鉴定。材料与方法:我们分析了两个染色体基因座的杂合度(LOH)的丧失。使用遗传标记D16S303,D16S3026和D16S3407的16q24.3,以及b。使用微卫星标记D16S503,D16S752和D16S512,E-cadherin基因的基因座16q22.1用于一系列由63例导管癌,4例小叶癌和3例混合型肿瘤组成的63例散发性浸润性乳腺癌。我们的发现与肿瘤的增殖活性,倍性和激素状态相关。结果:十四个肿瘤(22.2%)表现出LOq为16q24.3。在61例资料丰富的病例中有19例(31%)发现16q22.1基因座的等位基因失衡,并且通常与16q24.3的LOH共存。观察到D16S752的LOH与肿瘤细胞中孕酮受体的缺失之间存在显着关联(p = 0.005)。结论:16q24.3和16q22.1的LOH是乳腺癌中常见的遗传改变,似乎与肿瘤细胞的增殖或倍性无关。 16q24.3的LOH与孕激素受体之间的统计关联需要在更大的系列中进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号